Upper Respiratory Tract InfectionNCT06816875
Comparison of the User Experience of Four Nasal Aspirators in Infants
A study testing NozeBot Electric Nasal Aspirator, NoseFrida the SnotSucker and hydraSense Baby Nasal Care Nasal Aspirator Starter Kit in people with Upper Respiratory Tract Infection, run by Children's Hospital of Eastern Ontario at 1 site in Canada.
Trial summary
The goal of this clinical trial is to compare the caregiver's user experience, and overall impacts on an infant's cold symptoms between four nasal aspirator devices. These devices are normally used to relieve congestion in infants. when they are sick by softening and suctioning mucus from the nose. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Upper Respiratory Tract Infection
- What is being tested?
- NozeBot Electric Nasal Aspirator, NoseFrida the SnotSucker and hydraSense Baby Nasal Care Nasal Aspirator Starter Kit
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 28 participants
- Where
- 1 siteCanada
- Study dates
- 5 Mar 2025to 17 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- A parent(s)/caregiver(s)/family will be eligible to participate if:
- They have a child between 2 months - 18 months of age
- They are seeking outpatient care for that child for a respiratory illness (cold, flu, RSV) at the Kids Come First Care clinic
- The child does not have any contraindications to the use of a nasal aspirator
- The parent(s)/caregiver(s) are fluent in English
Who cannot join
- A parent(s)/caregiver(s)/family will be ineligible to participate if:
- They have a child younger than 2 months or 13 months old or older currently seeking outpatient care for a respiratory illness
- The child is admitted to hospital
- The child does not have a respiratory illness
- The child has a diagnosed craniofacial syndrome
- The child has a defined contraindication and cannot use a nasal aspirator
- The parents/caregivers are not comfortable using a nasal aspirator
- The parent/caregivers are not fluent in English
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Comparative Analysis of Commercially Available Nasal Aspirators in Infants
The goal of this clinical trial is to compare the caregiver's user experience, and overall impacts on an infant's cold symptoms between four nasal aspirator devices. These devices are normally used to relieve congestion in infants. when they are sick by softening and suctioning mucus from the nose.
The main questions it aims to answer are:
Read more
What is the caregiver's user experience of the NozeBot electric nasal aspirator compared to three commonly accessible nasal aspirator devices?
Are there changes in the infant's sleeping, feeding, or breathing as reported by the caregiver when using the NozeBot compared to the three other nasal aspirator devices?
Are there changes in their caregiver's habits when using the NozeBot compared to the three other nasal aspirator devices?
Researchers will compare the self-reported measures of caregiver's user experience, reported changes to their infant's symptoms, and reported changes to their own sleeping and care habits between the NozeBot electric nasal aspirator and three comparator devices: the NoseFrida SnotSucker, the hydraSense Baby Nasal Aspirator Kit, and the Braun electric nasal aspirator.
Participants will be assigned to receive one of the four devices at the start of their participation. They will be asked to use the assigned device at home according to the device instructions during two periods: (1) for 10 days while their infant is sick, and (2) for up to 3 months after.
During these periods, participants will be asked to complete online surveys at predetermined intervals to report the user experience, any changes to their infant's sleeping, feeding or breathing, and any changes to their own sleeping habits and perceived stress levels. These intervals for survey completion are: (i) after 1-2 days of use while their infant is sick, (ii) after 4-5 days of use while their infant is sick, (iii) after 7-10 days of use while their infant is sick, and then (iv) biweekly for 3 months.
- Conditions
- Upper Respiratory Tract Infection
- Being tested
- NozeBot Electric Nasal Aspirator, NoseFrida the SnotSucker, hydraSense Baby Nasal Care Nasal Aspirator Starter Kit, Braun Nasal Aspirator
- Keywords
- nasal aspirator in infants, user experience of nasal aspirators
- Medical subject headings
- Respiratory Tract Infections
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
NozeBot Electric Nasal AspiratorDevice
The NozeBot is a rechargeable, battery-operated baby nasal aspirator with a nosepiece that loops directly onto the caregivers fingers for ease of use, and is intended to be held so it sits just inside the nose to create a seal. It will be used according to its manufacturer's instructions for use in this study.
NoseFrida the SnotSuckerDevice
The NoseFrida is nose-to-mouth nasal suctioning device with a disposable hygienic filter. The nosepiece is a larger tube that is to be held so it sits against and not inside the nose to create a seal. It will be used according to its manufacturer's instructions for use in this study.
hydraSense Baby Nasal Care Nasal Aspirator Starter KitDevice
The hydraSense Baby Nasal Aspirator Starter Kit is a nose-to-mouth nasal suctioning device with a disposable hygienic filter. The kit contains pre-proportioned saline solution vials to liquify mucus prior to suctioning. The nosepiece is intended to be held so it sits inside the nose to create a seal. It will be used according to its manufacturer's instructions for use in this study.
Braun Nasal AspiratorDevice
The Braun nasal aspirator is a battery-operated nasal suctioning device with a washable collection chamber for mucus. There are two nosepiece sizes to accommodate a best fit in the nose. It will be used according to its manufacturer's instructions for use in this study.
| Study group | Role | What they receive |
|---|---|---|
| NozeBot Arm | Experimental | Participants assigned to this group will receive the NozeBot electric nasal aspirator device. Receives: Device: NozeBot Electric Nasal Aspirator |
| NoseFrida Arm | Active comparator | Participants assigned to this group will receive NoseFrida the SnotSucker product. Receives: Device: NoseFrida the SnotSucker |
| hydraSense Arm | Active comparator | Participants assigned to this group will receive the hydraSense Baby Nasal Aspirator Starter Kit. Receives: Device: hydraSense Baby Nasal Care Nasal Aspirator Starter Kit |
| Braun Arm | Active comparator | Participants assigned to this group will receive the Braun nasal aspirator device. Receives: Device: Braun Nasal Aspirator |
What is being measured
The primary outcome is the main question the study is designed to answer.
Differences in the caregiver's user experience on device ease of use between the NozeBot and the NoseFrida, hydraSense and Braun devices
The first measure of user experience is the self-reported rating by the caregivers on the ease of use of the device, including device set up, use, and cleaning after use. This is reported on a 5-point Likert scale (1 - difficult to 5 - easy) at each of the survey follow ups.
Measured: This is reported at all follow ups, from the first survey completed at 1-2 days of device use to the final survey completed at the end of the third month of use per participant
Differences in the caregiver's satisfaction between the NozeBot and the NoseFrida, hydraSense and Braun devices
The second measure of user experience is the caregiver-reported satisfaction with the device, including confidence that the device is helping their infant, and that the device's power is sufficiently removing mucus. This is reported on a 5-point Likert scale (1 - very dissatisfied to 5 - very satisfied) once at the 7-10 days of use while their child is sick, and at each bi-weekly survey over the 3 months.
Measured: This is reported at the 7-10 days of device use to the final survey completed at the end of the third month of use per participant.
Differences in the caregiver's reported net promoter score between the NozeBot and the NoseFrida, hydraSense and Braun devices
The third measure of user experience is the a rating by the caregiver on whether they would recommend the device to someone when their child is sick (also known as Net Promoter Score). This is reported on a 5-point Likert scale (1 - very unlikely to 5 - very likely) once at the 7-10 days of use while their chlid is sick, and at each bi-weekly survey over the 3 months.
Measured: This is reported at the 7-10 days of device use to the final survey completed at the end of the third month of use per participant.
Secondary outcomes (6)
Self-reported changes in the caregiver's sleep habits between the NozeBot and the NoseFrida, hydraSense and Braun devices
Recorded as self-reported perceived changes to the caregivers' sleeping habits during the time that their child is sick since they started using the device in the study. This is reported on a 5-point Likert scale (1 - much less than normal to 5 - a lot more than normal) at the 1-2 days of use, 4-5 days of use, and 7-10 days of use follow up surveys.
Measured: This is reported at the 1-2 days of use, 4-5 days of use, and 7-10 days of use follow up surveys.
Self-reported changes in the caregiver's perceived ability to care for their sick child between the NozeBot and the NoseFrida, hydraSense and Braun devices
Recorded as self-reported perceived changes to the caregivers' ability to take care of their child during the time that their child is sick since they started using the device in the study. This is reported on a 5-point Likert scale (1- much less able to 5 - a lot more capable) at each of the survey follow ups.
Measured: This is reported at all follow ups, from the first survey completed at 1-2 days of device use to the final survey completed at the end of the third month of use per participant
Self-reported changes in the caregiver's perceived stress levels while caring for a sick child between the NozeBot and the NoseFrida, hydraSense and Braun devices
Recorded as self-reported perceived changes to the caregivers' stress levels experienced while their child is sick since they started using the device in the study. This is reported on a 5-point Likert scale (1- strongly disagree to 5 - strongly agree) at each of the survey follow ups.
Measured: This is reported at all follow ups, from the first survey completed at 1-2 days of device use to the final survey completed at the end of the third month of use per participant
Caregiver-reported changes in their infant's sleeping habits between the NozeBot and the NoseFrida, hydraSense and Braun devices
Reported as caregiver-rated perceived changes in their infant's sleeping habits since they started using the device in the study on a 7-point Likert scale (1 - sleeping much worse to 4 - no changes in sleep to 7 - sleeping much better).
Measured: This is reported at the 1-2 days of use, 4-5 days of use, and 7-10 days of use follow up surveys.
Caregiver-reported changes in their infant's feeding habits between the NozeBot and the NoseFrida, hydraSense and Braun devices
Reported as caregiver-rated perceived changes in their infant's feeding habits since they started using the device in the study on a 7-point Likert scale (1 - much harder to feed to 4 - no changes to feeding to 7 - much easier to feed).
Measured: This is reported at the 1-2 days of use, 4-5 days of use, and 7-10 days of use follow up surveys.
Caregiver-reported perceived changes in their infant's breathing between the NozeBot and the NoseFrida, hydraSense and Braun devices
Reported as caregiver-rated perceived changes in their infant's breathing since they started using the device in the study on a 4-point Likert scale (1 - no change in breathing to 4 - breathing a lot better).
Measured: This is reported at all follow ups, from the first survey completed at 1-2 days of device use to the final survey completed at the end of the third month of use per participant
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Feb 2025
- Study start5 Mar 2025
- Primary completion17 Dec 2025
- Study completion17 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Upper Respiratory Tract InfectionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 28 participants (actual)
Sponsor and investigators
- Lead sponsor
- Children's Hospital of Eastern Ontario
- Sponsor type
- University, hospital or other
- Collaborators
- Dr. Noze Best LLC
- Responsible party
- Principal investigator, Valerie Cote, Children's Hospital of Eastern Ontario
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06816875
- Sponsor's protocol ID
- CHEO REB# 25/07X
- Status last verified
- Mar 2026
- First submitted
- 27 Jan 2025
- Last updated
- 2 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- Yes: Data collected for this research may be used in future related research projects that are either an extension of the original project or in the same general area of research (secondary use of data). Researchers outside of this specific study may request access to the coded database for new research purposes with a specific study plan and agreement to use the coded data only for that research. Participants will not be asked to provide additional informed consent for the use of their coded data for future research. As this study is being conducted to compare the user experience of the NozeBot to three competitor devices, future data sharing requests will be reviewed and allowed in collaboration with Dr. Noze Best.
Study at a glance
From the registry record, last updated by the sponsor on 2 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparative Analysis of Commercially Available Nasal Aspirators in Infants
- ClinicalTrials.gov ID
- NCT06816875
- Acronym / sponsor ID
- CHEO REB# 25/07X
- Conditions
- Upper Respiratory Tract Infection
- Keywords
- nasal aspirator in infants, user experience of nasal aspirators
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 28 participants (actual)
- Lead sponsor
- Children's Hospital of Eastern OntarioUniversity, hospital or other
- Collaborators
- Dr. Noze Best LLC
- Study start
- 5 Mar 2025 (actual)
- Primary completion
- 17 Dec 2025 (actual)
- Study completion
- 17 Dec 2025 (actual)
- First posted
- 10 Feb 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to compare the caregiver's user experience, and overall impacts on an infant's cold symptoms between four nasal aspirator devices. These devices are normally used to relieve congestion in infants. when they are sick by softening and suctioning mucus from the nose.
The main questions it aims to answer are:
What is the caregiver's user experience of the NozeBot electric nasal aspirator compared to three commonly accessible nasal aspirator devices?
Are there changes in the infant's sleeping, feeding, or breathing as reported by the caregiver when using the NozeBot compared to the three other nasal aspirator devices?
Are there changes in their caregiver's habits when using the NozeBot compared to the three other nasal aspirator devices?
Researchers will compare the self-reported measures of caregiver's user experience, reported changes to their infant's symptoms, and reported changes to their own sleeping and care habits between the NozeBot electric nasal aspirator and three comparator devices: the NoseFrida SnotSucker, the hydraSense Baby Nasal Aspirator Kit, and the Braun electric nasal aspirator.
Participants will be assigned to receive one of the four devices at the start of their participation. They will be asked to use the assigned device at home according to the device instructions during two periods: (1) for 10 days while their infant is sick, and (2) for up to 3 months after.
During these periods, participants will be asked to complete online surveys at predetermined intervals to report the user experience, any changes to their infant's sleeping, feeding or breathing, and any changes to their own sleeping habits and perceived stress levels. These intervals for survey completion are: (i) after 1-2 days of use while their infant is sick, (ii) after 4-5 days of use while their infant is sick, (iii) after 7-10 days of use while their infant is sick, and then (iv) biweekly for 3 months.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| NozeBot Arm | Experimental | Device: NozeBot Electric Nasal AspiratorParticipants assigned to this group will receive the NozeBot electric nasal aspirator device. |
| NoseFrida Arm | Active comparator | Device: NoseFrida the SnotSuckerParticipants assigned to this group will receive NoseFrida the SnotSucker product. |
| hydraSense Arm | Active comparator | Device: hydraSense Baby Nasal Care Nasal Aspirator Starter KitParticipants assigned to this group will receive the hydraSense Baby Nasal Aspirator Starter Kit. |
| Braun Arm | Active comparator | Device: Braun Nasal AspiratorParticipants assigned to this group will receive the Braun nasal aspirator device. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (5 listed)
- They have a child between 2 months - 18 months of age
- They are seeking outpatient care for that child for a respiratory illness (cold, flu, RSV) at the Kids Come First Care clinic
- The child does not have any contraindications to the use of a nasal aspirator
- The parent(s)/caregiver(s) are fluent in English
Key exclusion criteria (8 listed)
- They have a child younger than 2 months or 13 months old or older currently seeking outpatient care for a respiratory illness
- The child is admitted to hospital
- The child does not have a respiratory illness
- The child has a diagnosed craniofacial syndrome
- The child has a defined contraindication and cannot use a nasal aspirator
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| NozeBot Electric Nasal AspiratorThe NozeBot is a rechargeable, battery-operated baby nasal aspirator with a nosepiece that loops directly onto the caregivers fingers for ease of use, and is intended to be held so it sits just inside the nose to create a seal. It will be used according to its manufacturer's instructions for use in this study. | Device | NozeBot Arm |
| NoseFrida the SnotSuckerThe NoseFrida is nose-to-mouth nasal suctioning device with a disposable hygienic filter. The nosepiece is a larger tube that is to be held so it sits against and not inside the nose to create a seal. It will be used according to its manufacturer's instructions for use in this study. | Device | NoseFrida Arm |
| hydraSense Baby Nasal Care Nasal Aspirator Starter KitThe hydraSense Baby Nasal Aspirator Starter Kit is a nose-to-mouth nasal suctioning device with a disposable hygienic filter. The kit contains pre-proportioned saline solution vials to liquify mucus prior to suctioning. The nosepiece is intended to be held so it sits inside the nose to create a seal. It will be used according to its manufacturer's instructions for use in this study. | Device | hydraSense Arm |
| Braun Nasal AspiratorThe Braun nasal aspirator is a battery-operated nasal suctioning device with a washable collection chamber for mucus. There are two nosepiece sizes to accommodate a best fit in the nose. It will be used according to its manufacturer's instructions for use in this study. | Device | Braun Arm |
Primary outcome
Differences in the caregiver's user experience on device ease of use between the NozeBot and the NoseFrida, hydraSense and Braun devices
Time frame: This is reported at all follow ups, from the first survey completed at 1-2 days of device use to the final survey completed at the end of the third month of use per participant
The first measure of user experience is the self-reported rating by the caregivers on the ease of use of the device, including device set up, use, and cleaning after use. This is reported on a 5-point Likert scale (1 - difficult to 5 - easy) at each of the survey follow ups.
Differences in the caregiver's satisfaction between the NozeBot and the NoseFrida, hydraSense and Braun devices
Time frame: This is reported at the 7-10 days of device use to the final survey completed at the end of the third month of use per participant.
The second measure of user experience is the caregiver-reported satisfaction with the device, including confidence that the device is helping their infant, and that the device's power is sufficiently removing mucus. This is reported on a 5-point Likert scale (1 - very dissatisfied to 5 - very satisfied) once at the 7-10 days of use while their child is sick, and at each bi-weekly survey over the 3 months.
Differences in the caregiver's reported net promoter score between the NozeBot and the NoseFrida, hydraSense and Braun devices
Time frame: This is reported at the 7-10 days of device use to the final survey completed at the end of the third month of use per participant.
The third measure of user experience is the a rating by the caregiver on whether they would recommend the device to someone when their child is sick (also known as Net Promoter Score). This is reported on a 5-point Likert scale (1 - very unlikely to 5 - very likely) once at the 7-10 days of use while their chlid is sick, and at each bi-weekly survey over the 3 months.
6 secondary outcomes
Self-reported changes in the caregiver's sleep habits between the NozeBot and the NoseFrida, hydraSense and Braun devices
Time frame: This is reported at the 1-2 days of use, 4-5 days of use, and 7-10 days of use follow up surveys.
Self-reported changes in the caregiver's perceived ability to care for their sick child between the NozeBot and the NoseFrida, hydraSense and Braun devices
Time frame: This is reported at all follow ups, from the first survey completed at 1-2 days of device use to the final survey completed at the end of the third month of use per participant
Self-reported changes in the caregiver's perceived stress levels while caring for a sick child between the NozeBot and the NoseFrida, hydraSense and Braun devices
Time frame: This is reported at all follow ups, from the first survey completed at 1-2 days of device use to the final survey completed at the end of the third month of use per participant
Caregiver-reported changes in their infant's sleeping habits between the NozeBot and the NoseFrida, hydraSense and Braun devices
Time frame: This is reported at the 1-2 days of use, 4-5 days of use, and 7-10 days of use follow up surveys.
Caregiver-reported changes in their infant's feeding habits between the NozeBot and the NoseFrida, hydraSense and Braun devices
Time frame: This is reported at the 1-2 days of use, 4-5 days of use, and 7-10 days of use follow up surveys.
Caregiver-reported perceived changes in their infant's breathing between the NozeBot and the NoseFrida, hydraSense and Braun devices
Time frame: This is reported at all follow ups, from the first survey completed at 1-2 days of device use to the final survey completed at the end of the third month of use per participant
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Apr 2026.
- Individual participant dataSharing planned: Yes. Data collected for this research may be used in future related research projects that are either an extension of the original project or in the same general area of research (secondary use of data). Researchers outside of this specific study may request access to the coded database for new research purposes with a specific study plan and agreement to use the coded data only for that research. Participants will not be asked to provide additional informed consent for the use of their coded data for future research. As this study is being conducted to compare the user experience of the NozeBot to three competitor devices, future data sharing requests will be reviewed and allowed in collaboration with Dr. Noze Best.
Related trials for Upper Respiratory Tract Infection
RecruitingPhase 1
A Clinical Trial of V175 and V175A in Healthy Adults
Lower Respiratory Tract Infection
Not yet recruiting
Influence of Patient Positioning During Nasal Lavage
Acute Upper Respiratory Tract Infections, Nasal Obstruction
Recruiting
The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)
Lower Respiratory Tract Infection
RecruitingPhase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Respiratory Tract Diseases, Influenza (Pandemic)
Recruiting
Vocxi Breath Analyzer Study in Pediatric Respiratory Infection
Acute Respiratory Illness, Viral Respiratory Infection
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing NozeBot Electric Nasal Aspirator, NoseFrida the SnotSucker and hydraSense Baby Nasal Care Nasal Aspirator Starter Kit in people with Upper Respiratory Tract Infection, run by Children's Hospital of Eastern Ontario at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Differences in the caregiver's user experience on device ease of use between the NozeBot and the NoseFrida, hydraSense and Braun devices (time frame: This is reported at all follow ups, from the first survey completed at 1-2 days of device use to the final survey completed at the end of the third month of use per participant). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2026.